Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy
Authors
Keywords
-
Journal
Biomarker Research
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-10-24
DOI
10.1186/s40364-021-00333-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor interferon signaling and suppressive myeloid cells associate with CAR T cell failure in large B cell lymphoma
- (2021) Michael D. Jain et al. BLOOD
- Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma
- (2021) Toni K. Choueiri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Modulating tumor infiltrating myeloid cells to enhance bispecific antibody-driven T cell infiltration and anti-tumor response
- (2021) Jeong A. Park et al. Journal of Hematology & Oncology
- Myeloid-derived suppressor cells—new and exciting players in lung cancer
- (2020) Zhenzhen Yang et al. Journal of Hematology & Oncology
- Therapeutic Targeting of Vasculature in the Premetastatic and Metastatic Niches Reduces Lung Metastasis
- (2020) Shanawaz M. Ghouse et al. JOURNAL OF IMMUNOLOGY
- Epigenetic therapy inhibits metastases by disrupting premetastatic niches
- (2020) Zhihao Lu et al. NATURE
- Activated Hepatic Stellate Cells (HSCs) Exert Immunosuppressive Effects in Hepatocellular Carcinoma by Producing Complement C3
- (2020) Yaping Xu et al. OncoTargets and Therapy
- Valproic acid attenuates CCR2-dependent tumor infiltration of monocytic myeloid-derived suppressor cells, limiting tumor progression
- (2020) Zhiqi Xie et al. OncoImmunology
- Selective targeting of different populations of myeloid-derived suppressor cells by histone deacetylase inhibitors
- (2020) Ayumi Hashimoto et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Myeloid‐derived suppressor cells promote epithelial ovarian cancer cell stemness by inducing the CSF2/p‐STAT3 signalling pathway
- (2020) Xiaofeng Li et al. FEBS Journal
- Porphyromonas gingivalis Promotes Oral Squamous Cell Carcinoma Progression in an Immune Microenvironment
- (2020) L. Wen et al. JOURNAL OF DENTAL RESEARCH
- PTGES/PGE2 signaling links immunosuppression and lung metastasis in Gprc5a-knockout mouse model
- (2020) Tong Wang et al. ONCOGENE
- Circulating Myeloid-derived Suppressor Cells Facilitate Invasion of Thyroid Cancer Cells by Repressing miR-486-3p
- (2020) Li Chen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Peripheral natural killer cells and myeloid-derived suppressor cells correlate with anti-PD-1 responses in non-small cell lung cancer
- (2020) Je-In Youn et al. Scientific Reports
- The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion
- (2020) Paola De Cicco et al. Frontiers in Immunology
- Gut microbiome directs hepatocytes to recruit MDSC and promote cholangiocarcinoma
- (2020) Qianfei Zhang et al. Cancer Discovery
- Tim-3/galectin-9 pathway and mMDSC control primary and secondary resistances to PD-1 blockade in lung cancer patients
- (2019) Emeric Limagne et al. OncoImmunology
- Suppression of Myeloid Cell Arginase Activity leads to Therapeutic Response in a NSCLC Mouse Model by Activating Anti-Tumor Immunity
- (2019) Juan J. Miret et al. Journal for ImmunoTherapy of Cancer
- Early-Life Microbiota Exposure Restricts Myeloid-Derived Suppressor Cell–Driven Colonic Tumorigenesis
- (2019) Akihito Harusato et al. Cancer Immunology Research
- GNAI1 and GNAI3 Reduce Colitis-Associated Tumorigenesis in Mice by Blocking IL6 Signaling and Downregulating Expression of GNAI2
- (2019) Zhi-Wei Li et al. GASTROENTEROLOGY
- Aurora-A inhibition eliminates myeloid cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in breast cancer
- (2019) Tingting Yin et al. CANCER RESEARCH
- Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates
- (2019) Luca Cassetta et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer
- (2019) Wenting Liao et al. CANCER CELL
- Vasohibin‐2 plays an essential role in metastasis of pancreatic ductal adenocarcinoma
- (2019) Rie Iida‐Norita et al. CANCER SCIENCE
- RIP 3 deficiency recruits myeloid‐derived suppressor cells to hepatocellular carcinoma through the CXCL 1‐ CXCR 2 axis
- (2019) Yi‐Ming Li et al. HEPATOLOGY
- PMN-MDSCs Enhance CTC Metastatic Properties through Reciprocal Interactions via ROS/Notch/Nodal Signaling
- (2019) Marc L. Sprouse et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Myeloid-derived suppressor cells endow stem-like qualities to multiple myeloma cells by inducing piRNA-823 expression and DNMT3B activation
- (2019) Lisha Ai et al. Molecular Cancer
- RS 504393 inhibits M-MDSCs recruiting in immune microenvironment of bladder cancer after gemcitabine treatment
- (2019) Xing-Yu Mu et al. MOLECULAR IMMUNOLOGY
- Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies
- (2019) Ivan Perrot et al. Cell Reports
- Hypoxia-induced VISTA promotes the suppressive function of myeloid- derived suppressor cells in the tumor microenvironment
- (2019) Jie Deng et al. Cancer Immunology Research
- Melanoma extracellular vesicles generate immunosuppressive myeloid cells by PD-L1 upregulation via TLR4 signaling
- (2019) Viktor Fleming et al. CANCER RESEARCH
- Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapy
- (2019) A. Passaro et al. Clinical & Translational Oncology
- Upregulation of IL-6 in CUL4B-deficient myeloid-derived suppressive cells increases the aggressiveness of cancer cells
- (2019) Zhiliang Xu et al. ONCOGENE
- CXCR4 antagonism in combination with IDO1 inhibition weakens immune suppression and inhibits tumor growth in mouse breast cancer bone metastases
- (2019) Jian Zhang et al. OncoTargets and Therapy
- Granulocytic Myeloid‐Derived Suppressor Cells Promote the Stemness of Colorectal Cancer Cells through Exosomal S100A9
- (2019) Yungang Wang et al. Advanced Science
- SPARC Is a New Myeloid-Derived Suppressor Cell Marker Licensing Suppressive Activities
- (2019) Sabina Sangaletti et al. Frontiers in Immunology
- Perforin and Granzyme B Expressed by Murine Myeloid-Derived Suppressor Cells: A Study on Their Role in Outgrowth of Cancer Cells
- (2019) Inès Dufait et al. Cancers
- Survival of the fittest: how myeloid-derived suppressor cells survive in the inhospitable tumor microenvironment
- (2019) Suzanne Ostrand-Rosenberg et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor-induced peripheral immunosuppression promotes brain metastasis in patients with non-small cell lung cancer
- (2019) Yuping D. Li et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study
- (2019) Georgina V Long et al. LANCET ONCOLOGY
- Lactoferrin deficiency induces a pro-metastatic tumor microenvironment through recruiting myeloid-derived suppressor cells in mice
- (2019) Lingyu Wei et al. ONCOGENE
- The mechanism of the premetastatic niche facilitating colorectal cancer liver metastasis generated from myeloid-derived suppressor cells induced by the S1PR1–STAT3 signaling pathway
- (2019) Qi Lin et al. Cell Death & Disease
- Myeloid-derived suppressive cells promote B cell-mediated immunosuppression via transfer of PD-L1 in glioblastoma
- (2019) Catalina Lee-Chang et al. Cancer Immunology Research
- S100A9 Regulates MDSCs-Mediated Immune Suppression via the RAGE and TLR4 Signaling Pathways in Colorectal Carcinoma
- (2019) Mao Huang et al. Frontiers in Immunology
- Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3
- (2019) Rosalinda Trovato et al. Journal for ImmunoTherapy of Cancer
- Cancer-Derived VEGF-C Increases Chemokine Production in Lymphatic Endothelial Cells to Promote CXCR2-Dependent Cancer Invasion and MDSC Recruitment
- (2019) Jing-Yi Chen et al. Cancers
- Myeloid-Derived Suppressor Cells Promote Metastasis in Breast Cancer After the Stress of Operative Removal of the Primary Cancer
- (2019) Xuelei Ma et al. Frontiers in Oncology
- Activated hepatic stellate cells regulate MDSC migration through the SDF-1/CXCR4 axis in an orthotopic mouse model of hepatocellular carcinoma
- (2019) Yaping Xu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- SDF-1/CXCR4 axis facilitates myeloid-derived suppressor cells accumulation in osteosarcoma microenvironment and blunts the response to anti-PD-1 therapy
- (2019) Kuo Jiang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Microsomal prostaglandin E synthase-1 promotes lung metastasis via SDF-1/CXCR4-mediated recruitment of CD11b+Gr1+MDSCs from bone marrow
- (2019) Ryo Takahashi et al. BIOMEDICINE & PHARMACOTHERAPY
- PAR2 deficiency enhances myeloid cell-mediated immunosuppression and promotes colitis-associated tumorigenesis
- (2019) Ziliang Ke et al. CANCER LETTERS
- IL6/STAT3 Signaling Orchestrates Premetastatic Niche Formation and Immunosuppressive Traits in Lung
- (2019) Bo Jing et al. CANCER RESEARCH
- Cabozantinib in Combination with Immunotherapy for Advanced Renal Cell Carcinoma and Urothelial Carcinoma: Rationale and Clinical Evidence
- (2019) Paulo Bergerot et al. MOLECULAR CANCER THERAPEUTICS
- Chemokines and their receptors promoting the recruitment of myeloid-derived suppressor cells into the tumor
- (2019) Bao-Hua Li et al. MOLECULAR IMMUNOLOGY
- CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas
- (2019) Joseph A. Flores-Toro et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer-educated mesenchymal stem cells promote the survival of cancer cells at primary and distant metastatic sites via the expansion of bone marrow-derived-PMN-MDSCs
- (2019) Buqing Sai et al. Cell Death & Disease
- 1α, 25 Dihydroxyvitamin D (1,25(OH)2D) inhibits the T cell suppressive function of myeloid derived suppressor cells (MDSC)
- (2019) J.C. Fleet et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Lung resided monocytic myeloid-derived suppressor cells contribute to premetastatic niche formation by enhancing MMP-9 expression
- (2019) Juechao Zhang et al. MOLECULAR AND CELLULAR PROBES
- The potential predictive value of circulating immune cell ratio and tumor marker in atezolizumab treated advanced non-small cell lung cancer patients
- (2018) Minglei Zhuo et al. Cancer Biomarkers
- How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions
- (2018) Annika M. Bruger et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Metformin-Induced Reduction of CD39 and CD73 Blocks Myeloid-Derived Suppressor Cell Activity in Patients with Ovarian Cancer
- (2018) Lifeng Li et al. CANCER RESEARCH
- Blockade of myeloid-derived suppressor cell expansion with all-trans retinoic acid increases the efficacy of anti-angiogenic therapy
- (2018) Raimund Bauer et al. CANCER RESEARCH
- A RIPK3-PGE2 circuit mediates myeloid-derived suppressor cell-potentiated colorectal carcinogenesis
- (2018) Guifang Yan et al. CANCER RESEARCH
- The Highly Metastatic Nature of Uterine Cervical/Endometrial Cancer Displaying Tumor-Related Leukocytosis: Clinical and Preclinical Investigations
- (2018) Tomoyuki Sasano et al. CLINICAL CANCER RESEARCH
- Clinical relevance and suppressive capacity of human MDSC subsets
- (2018) Stephan Lang et al. CLINICAL CANCER RESEARCH
- Characterization of Multiple Cytokine Combinations and TGF-β on Differentiation and Functions of Myeloid-Derived Suppressor Cells
- (2018) Cho-Rong Lee et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Myeloid-Derived Suppressor Cells Impair B Cell Responses in Lung Cancer through IL-7 and STAT5
- (2018) Yong Wang et al. JOURNAL OF IMMUNOLOGY
- Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation
- (2018) Mana Taki et al. Nature Communications
- A novel MDSC-induced PD-1−PD-L1+ B-cell subset in breast tumor microenvironment possesses immuno-suppressive properties
- (2018) Meng Shen et al. OncoImmunology
- The Adaptor Protein CARD9 Protects against Colon Cancer by Restricting Mycobiota-Mediated Expansion of Myeloid-Derived Suppressor Cells
- (2018) Tingting Wang et al. IMMUNITY
- STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells
- (2018) Prajna Guha et al. ONCOGENE
- TGF-β1 programmed myeloid-derived suppressor cells (MDSC) acquire immune-stimulating and tumor killing activity capable of rejecting established tumors in combination with radiotherapy
- (2018) Padmini Jayaraman et al. OncoImmunology
- ΔNp63-driven recruitment of myeloid-derived suppressor cells promotes metastasis in triple-negative breast cancer
- (2018) Sushil Kumar et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy
- (2018) Priyamvada Jayaprakash et al. JOURNAL OF CLINICAL INVESTIGATION
- Myeloid-Derived Suppressor Cells Produce IL-10 to Elicit DNMT3b-Dependent IRF8 Silencing to Promote Colitis-Associated Colon Tumorigenesis
- (2018) Mohammed L. Ibrahim et al. Cell Reports
- Presence of Infected Gr-1intCD11bhiCD11cint Monocytic Myeloid Derived Suppressor Cells Subverts T Cell Response and Is Associated With Impaired Dendritic Cell Function in Mycobacterium avium-Infected Mice
- (2018) Ketema Abdissa et al. Frontiers in Immunology
- Reactive Oxygen Species as Regulators of MDSC-Mediated Immune Suppression
- (2018) Kim Ohl et al. Frontiers in Immunology
- Toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cells
- (2018) Marion Dajon et al. OncoImmunology
- Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations
- (2018) Fatima Karzai et al. Journal for ImmunoTherapy of Cancer
- PRKCI promotes immune suppression in ovarian cancer
- (2017) Sharmistha Sarkar et al. GENES & DEVELOPMENT
- Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy
- (2017) Jingying Zhou et al. GUT
- Circulating CD14+ HLA-DR−/low myeloid-derived suppressor cells predicted early recurrence of hepatocellular carcinoma after surgery
- (2017) Xing-Hui Gao et al. HEPATOLOGY RESEARCH
- An Immunogram for the Cancer-Immunity Cycle: Towards Personalized Immunotherapy of Lung Cancer
- (2017) Takahiro Karasaki et al. Journal of Thoracic Oncology
- Myeloid-derived suppressor cells are increased and correlated with type 2 immune responses, malnutrition, inflammation, and poor prognosis in patients with breast cancer
- (2017) Kenji Gonda et al. Oncology Letters
- Accumulation of myeloid-derived suppressor cells (MDSCs) induced by low levels of IL-6 correlates with poor prognosis in bladder cancer
- (2017) Guoliang Yang et al. Oncotarget
- The peripheral immune status of granulocytic myeloid-derived suppressor cells correlates the survival in advanced gastric cancer patients receiving cisplatin-based chemotherapy
- (2017) Hirokazu Shoji et al. Oncotarget
- Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma
- (2017) Yago Pico de Coana et al. Oncotarget
- Extracellular S100A9 Protein in Bone Marrow Supports Multiple Myeloma Survival by Stimulating Angiogenesis and Cytokine Secretion
- (2017) Kim De Veirman et al. Cancer Immunology Research
- Interleukin-6 Trans-Signaling Pathway Promotes Immunosuppressive Myeloid-Derived Suppressor Cells via Suppression of Suppressor of Cytokine Signaling 3 in Breast Cancer
- (2017) Mengmeng Jiang et al. Frontiers in Immunology
- CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF-β-mTOR-HIF-1 signaling in patients with non-small cell lung cancer
- (2017) Jieyao Li et al. OncoImmunology
- CD13hi Neutrophil-like myeloid-derived suppressor cells exert immune suppression through Arginase 1 expression in pancreatic ductal adenocarcinoma
- (2017) Jing Zhang et al. OncoImmunology
- Arginase inhibition suppresses lung metastasis in the 4T1 breast cancer model independently of the immunomodulatory and anti-metastatic effects of VEGFR-2 blockade
- (2017) Chiara Secondini et al. OncoImmunology
- The induction of human myeloid derived suppressor cells through hepatic stellate cells is dose-dependently inhibited by the tyrosine kinase inhibitors nilotinib, dasatinib and sorafenib, but not sunitinib
- (2016) Annkristin Heine et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Myeloid-derived suppressor cells correlate with patient outcomes in hepatic arterial infusion chemotherapy for hepatocellular carcinoma
- (2016) Eishiro Mizukoshi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib Treatment
- (2016) Andrew Stiff et al. CANCER RESEARCH
- Invariant NKT cells are resistant to circulating CD15+myeloid-derived suppressor cells in patients with head and neck cancer
- (2016) Atsushi Horinaka et al. CANCER SCIENCE
- Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab
- (2016) A. Martens et al. CLINICAL CANCER RESEARCH
- Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs)
- (2016) C. Alfaro et al. CLINICAL CANCER RESEARCH
- Clinical Significance of Circulating CD33+CD11b+HLA-DR- Myeloid Cells in Patients with Stage IV Melanoma Treated with Ipilimumab
- (2016) M. Sade-Feldman et al. CLINICAL CANCER RESEARCH
- Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Inhibits Tumor Immunity through the Accumulation of Myeloid-Derived Suppressor Cells
- (2016) Naoki Horikawa et al. CLINICAL CANCER RESEARCH
- Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26
- (2016) David Kung-Chun Chiu et al. HEPATOLOGY
- Myeloid-Derived Suppressor Cell Survival and Function Are Regulated by the Transcription Factor Nrf2
- (2016) Daniel W. Beury et al. JOURNAL OF IMMUNOLOGY
- Hepatitis C Virus–Induced Myeloid-Derived Suppressor Cells Suppress NK Cell IFN-γ Production by Altering Cellular Metabolism via Arginase-1
- (2016) Celeste C. Goh et al. JOURNAL OF IMMUNOLOGY
- Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells
- (2016) Y Deng et al. ONCOGENE
- The clinical and prognostic significance of CD14+HLA-DR−/low myeloid-derived suppressor cells in hepatocellular carcinoma patients receiving radiotherapy
- (2016) Dong Wang et al. TUMOR BIOLOGY
- Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
- (2016) Vincenzo Bronte et al. Nature Communications
- The prognostic effects of tumor infiltrating regulatory T cells and myeloid derived suppressor cells assessed by multicolor flow cytometry in gastric cancer patients
- (2016) Han Sol Choi et al. Oncotarget
- Myeloid-Derived Suppressor Cells Are Controlled by Regulatory T Cells via TGF-β during Murine Colitis
- (2016) Cho-Rong Lee et al. Cell Reports
- RNF20 Links Histone H2B Ubiquitylation with Inflammation and Inflammation-Associated Cancer
- (2016) Ohad Tarcic et al. Cell Reports
- Phase I/II Study of Metastatic Melanoma Patients Treated with Nivolumab Who Had Progressed after Ipilimumab
- (2016) J. Weber et al. Cancer Immunology Research
- Nitric oxide synthase 2 is involved in the pro-tumorigenic potential of γδ17 T cells in melanoma
- (2016) Laetitia Douguet et al. OncoImmunology
- Targeting inflammasome/IL-1 pathways for cancer immunotherapy
- (2016) Beichu Guo et al. Scientific Reports
- Increased circulating CD14(+)HLA-DR-/low myeloid-derived suppressor cells are associated with poor prognosis in patients with small-cell lung cancer
- (2015) Tian Tian et al. Cancer Biomarkers
- Immunological factors influencing clinical outcome in lung cancer patients after telomerase peptide vaccination
- (2015) Gaute Lund Hansen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Myeloid-derived suppressor cells inhibit T cell proliferation in human extranodal NK/T cell lymphoma: a novel prognostic indicator
- (2015) Han Zhang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Carbonic Anhydrase IX Promotes Myeloid-Derived Suppressor Cell Mobilization and Establishment of a Metastatic Niche by Stimulating G-CSF Production
- (2015) S. C. Chafe et al. CANCER RESEARCH
- Loss of SMAD4 Promotes Colorectal Cancer Progression by Accumulation of Myeloid-Derived Suppressor Cells through the CCL15-CCR1 Chemokine Axis
- (2015) S. Inamoto et al. CLINICAL CANCER RESEARCH
- Clinical significance of plasmacytoid dendritic cells and myeloid-derived suppressor cells in melanoma
- (2015) Ines Chevolet et al. Journal of Translational Medicine
- Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
- (2015) Jeffrey S Weber et al. LANCET ONCOLOGY
- Circulating CD14+HLA-DR−/low myeloid-derived suppressor cell is an indicator of poor prognosis in patients with ESCC
- (2015) Haitao Huang et al. TUMOR BIOLOGY
- Id1 suppresses anti-tumour immune responses and promotes tumour progression by impairing myeloid cell maturation
- (2015) Marianna Papaspyridonos et al. Nature Communications
- CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function
- (2015) Eunyoung Chun et al. Cell Reports
- PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid Cancer
- (2015) J. J. Severson et al. Cancer Immunology Research
- Immunoglobulin-like transcript 3 is expressed by myeloid-derived suppressor cells and correlates with survival in patients with non-small cell lung cancer
- (2015) Pauline L de Goeje et al. OncoImmunology
- Myeloid-derived suppressor cell heterogeneity in human cancers
- (2014) Samantha Solito et al. Annals of the New York Academy of Sciences
- A combination trial of vaccine plus ipilimumab in metastatic castration-resistant prostate cancer patients: immune correlates
- (2014) Caroline Jochems et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Myeloid Expression of Adenosine A2A Receptor Suppresses T and NK Cell Responses in the Solid Tumor Microenvironment
- (2014) C. Cekic et al. CANCER RESEARCH
- IL-17A Produced by T Cells Promotes Tumor Growth in Hepatocellular Carcinoma
- (2014) S. Ma et al. CANCER RESEARCH
- Inhibition of Tumor-Derived Prostaglandin-E2 Blocks the Induction of Myeloid-Derived Suppressor Cells and Recovers Natural Killer Cell Activity
- (2014) Y. Mao et al. CLINICAL CANCER RESEARCH
- Phenotypes, accumulation, and functions of myeloid-derived suppressor cells and associated treatment strategies in cancer patients
- (2014) Jingwei Jiang et al. HUMAN IMMUNOLOGY
- Elevated chronic inflammatory factors and myeloid-derived suppressor cells indicate poor prognosis in advanced melanoma patients
- (2014) Huanhuan Jiang et al. INTERNATIONAL JOURNAL OF CANCER
- PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation
- (2014) Muhammad Zaeem Noman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Treatment of Tumors with Vitamin E Suppresses Myeloid Derived Suppressor Cells and Enhances CD8+ T Cell-Mediated Antitumor Effects
- (2014) Tae Heung Kang et al. PLoS One
- Adjuvants and myeloid-derived suppressor cells: Enemies or allies in therapeutic cancer vaccination
- (2014) Audry Fernández et al. Human Vaccines & Immunotherapeutics
- Tasquinimod Modulates Suppressive Myeloid Cells and Enhances Cancer Immunotherapies in Murine Models
- (2014) L. Shen et al. Cancer Immunology Research
- A Circulating Subpopulation of Monocytic Myeloid-Derived Suppressor Cells as an Independent Prognostic/Predictive Factor in Untreated Non-Small Lung Cancer Patients
- (2014) Eleni-Kyriaki Vetsika et al. Journal of Immunology Research
- Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and ipilimumab
- (2014) Saskia JAM Santegoets et al. Journal for ImmunoTherapy of Cancer
- Efficacy and safety of ipilimumab in metastatic melanoma patients surviving more than 2 years following treatment in a phase III trial (MDX010-20)
- (2013) D. McDermott et al. ANNALS OF ONCOLOGY
- CXCR2-Expressing Myeloid-Derived Suppressor Cells Are Essential to Promote Colitis-Associated Tumorigenesis
- (2013) Hiroshi Katoh et al. CANCER CELL
- Myeloid-Derived Suppressor Cells Predict Survival of Patients with Advanced Melanoma: Comparison with Regulatory T Cells and NY-ESO-1- or Melan-A-Specific T Cells
- (2013) B. Weide et al. CLINICAL CANCER RESEARCH
- Loss of SMAD4 From Colorectal Cancer Cells Promotes CCL15 Expression to Recruit CCR1+ Myeloid Cells and Facilitate Liver Metastasis
- (2013) Yoshiro Itatani et al. GASTROENTEROLOGY
- Modulation of CD8+ T-cell activation events by monocytic and granulocytic myeloid-derived suppressor cells
- (2013) Elio Schouppe et al. IMMUNOBIOLOGY
- Adoptive cytotoxic T lymphocyte therapy triggers a counter-regulatory immunosuppressive mechanismviarecruitment of myeloid-derived suppressor cells
- (2013) Akihiro Hosoi et al. INTERNATIONAL JOURNAL OF CANCER
- Induction of myelodysplasia by myeloid-derived suppressor cells
- (2013) Xianghong Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Myeloid-Derived Suppressor Cells Suppress Antitumor Immune Responses through IDO Expression and Correlate with Lymph Node Metastasis in Patients with Breast Cancer
- (2013) J. Yu et al. JOURNAL OF IMMUNOLOGY
- Ipilimumab Treatment Results in an Early Decrease in the Frequency of Circulating Granulocytic Myeloid-Derived Suppressor Cells as well as Their Arginase1 Production
- (2013) Y. P. de Coana et al. Cancer Immunology Research
- Myeloid-Derived Suppressor Cells Attenuate TH1 Development through IL-6 Production to Promote Tumor Progression
- (2013) H. Tsukamoto et al. Cancer Immunology Research
- Immune Regulatory Activity of Vitamin D3 in Head and Neck Cancer
- (2013) M. Young et al. Cancers
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- Anti-IL-6 receptor mAb eliminates myeloid-derived suppressor cells and inhibits tumor growth by enhancing T-cell responses
- (2012) Kentaro Sumida et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Programmed Death-1+T Cells and Regulatory T Cells Are Enriched in Tumor-Involved Lymph Nodes and Associated with Aggressive Features in Papillary Thyroid Cancer
- (2012) Jena D. French et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Increased Myeloid-Derived Suppressor Cells in Gastric Cancer Correlate with Cancer Stage and Plasma S100A8/A9 Proinflammatory Proteins
- (2012) L. Wang et al. JOURNAL OF IMMUNOLOGY
- MicroRNA-494 Is Required for the Accumulation and Functions of Tumor-Expanded Myeloid-Derived Suppressor Cells via Targeting of PTEN
- (2012) Y. Liu et al. JOURNAL OF IMMUNOLOGY
- Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
- (2012) Steffen Walter et al. NATURE MEDICINE
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells
- (2011) N. Obermajer et al. BLOOD
- A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells
- (2011) S. Solito et al. BLOOD
- Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4+ T cells from patients with GI malignancy
- (2011) Bethany L. Mundy-Bosse et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13
- (2011) Rachel F. Gabitass et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- PGE2-Induced CXCL12 Production and CXCR4 Expression Controls the Accumulation of Human MDSCs in Ovarian Cancer Environment
- (2011) N. Obermajer et al. CANCER RESEARCH
- S100A8/A9 Activate Key Genes and Pathways in Colon Tumor Progression
- (2011) M. Ichikawa et al. MOLECULAR CANCER RESEARCH
- The PDL1-PD1 Axis Converts Human TH1 Cells into Regulatory T Cells
- (2011) S. Amarnath et al. Science Translational Medicine
- Mesenchymal Transition and Dissemination of Cancer Cells Is Driven by Myeloid-Derived Suppressor Cells Infiltrating the Primary Tumor
- (2011) Benjamin Toh et al. PLOS BIOLOGY
- TLR2-Mediated Expansion of MDSCs Is Dependent on the Source of Tumor Exosomes
- (2010) Xiaoyu Xiang et al. AMERICAN JOURNAL OF PATHOLOGY
- Direct and Differential Suppression of Myeloid-Derived Suppressor Cell Subsets by Sunitinib Is Compartmentally Constrained
- (2010) Jennifer S. Ko et al. CANCER RESEARCH
- CARD9 Mediates Dectin-2-induced IκBα Kinase Ubiquitination Leading to Activation of NF-κB in Response to Stimulation by the Hyphal Form ofCandida albicans
- (2010) Liangkuan Bi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
- (2009) Sergei Grivennikov et al. CANCER CELL
- Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor
- (2009) Bastian Hoechst et al. HEPATOLOGY
- The T-cell-receptor signaling network
- (2009) M. Huse JOURNAL OF CELL SCIENCE
- Fas Signal Promotes Lung Cancer Growth by Recruiting Myeloid-Derived Suppressor Cells via Cancer Cell-Derived PGE2
- (2009) Y. Zhang et al. JOURNAL OF IMMUNOLOGY
- IL4Rα + Myeloid-Derived Suppressor Cell Expansion in Cancer Patients
- (2009) Susanna Mandruzzato et al. JOURNAL OF IMMUNOLOGY
- Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity
- (2008) K. Movahedi et al. BLOOD
- Myeloid-Derived Suppressor Cells Promote Cross-Tolerance in B-Cell Lymphoma by Expanding Regulatory T Cells
- (2008) P. Serafini et al. CANCER RESEARCH
- Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein
- (2008) Pingyan Cheng et al. JOURNAL OF EXPERIMENTAL MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started